Genetics Based Medication Management: What Exactly is Precision Medicine?

Content

This article explores how individual genetic profiles influence medication responses, introducing the concept of precision medicine through pharmacogenomics.

The Problem with One-Size-Fits-All Medicine

A medication that works wonders for someone else produces no effect for you, or causes unexpected side effects. The reason lies in genetics. Pharmacogenomics is the study of how genetic traits influence individual responses to medications.

Despite advances in understanding this field, most practitioners continue using trial-and-error approaches. Research shows approximately 75% of patients experience suboptimal responses to standard drug therapy, resulting in wasted healthcare resources and unnecessary suffering.

How Genetic Variation Affects Drug Metabolism

The body metabolizes drugs at different rates depending on genetic variations. Some people process medications quickly, potentially losing therapeutic benefit before the drug takes effect. Others metabolize drugs slowly, risking dangerous buildup and toxicity.

The Drug Sensitivity Test

ZüpMed uses genetic testing to categorize patients into four metabolizer groups:

• Normal metabolizers: Expected standard therapeutic benefits
• Intermediate metabolizers: Slower breakdown; risk of buildup or reduced efficacy
• Poor metabolizers: Severe slowdown; toxicity risk even at low doses
• Ultra-rapid metabolizers: Quick breakdown; minimal therapeutic effect or dangerous surges

Benefits of Precision Medicine

This approach shifts from reactive to preventative prescribing, reducing adverse reactions and treatment failures while increasing patient adherence and treatment success. Over 200 FDA drug labels now include pharmacogenomic information, though this data proves most valuable when interpreted through individual genetic profiles.